Skip to main content

Valeant Pharmaceuticals will hold its annual meeting in Laval, Que., on Tuesday.

Christinne Muschi/Reuters

Economic confab

The three-day Economic Forum of the Americas begins in Montreal on Monday, featuring opening remarks from Montreal Mayor Denis Coderre and a news conference with Finance Minister Bill Morneau and OECD secretary-general Angel Gurria.

Valeant

Story continues below advertisement

The Montreal-based pharmaceutical giant holds its annual meeting in Laval, Que., on Tuesday. The company saw its stock tank last week to its lowest level in nearly six years after it slashed its outlook for the year and reported disappointing first-quarter results.

StatsCan

Statistics Canada releases the monthly survey of manufacturing for April on Wednesday, and on Friday releases the inflation figures for May. Last week's jobs numbers exceeded expectations.

TPP

International Trade Minister Chrystia Freeland hosts a public town hall meeting on the Trans-Pacific Partnership in Toronto on Wednesday. The deal aims to create a free-trade zone among 12 nations around the Pacific, making it the world's largest.

Birchmount

The class-action lawsuit filed by a team of shareholders of Birchmount Resources Ltd., with Hockey Hall-of-Famer Lanny McDonald as its representative plaintiff, is back in court in Calgary on Wednesday.

Story continues below advertisement

The lawsuit alleges Brookfield Asset Management acquired Birchmount's Hammerstone MegaQuarry using oppressive and misleading tactics, usurping shareholders and leaving them with nothing.

Report an error
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter